Is Harte Hanks Inc (HHS) overvalued? · rev $185.2M
Harte Hanks Inc (HHS) is a conglomerates company listed on US.
This page asks whether Harte Hanks Inc (HHS) looks expensive on cached numbers — not a short thesis.
Latest reported HHS revenue for 2024-12-31 was $185.2M. Net income was -$30.3M. Revenue was down 3.3% from 2023-12-31 to 2024-12-31. HHS currently screens at market cap $27.7M.
HHS currently screens at market cap $27.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HHS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HHS stock page for the full model, not this heading.
Not investment advice.